Post on 23-Jul-2020
HAI, NHSN and VBP: What’s New and What You Need To Know
Christine Martini-Bailey RN, BSN, CSSGB
Director, Quality Improvement and Patient Safety
Health Services Advisory Group (HSAG)
April 27, 2017
Objectives
• Review the 2017 updates to National Healthcare Safety Network (NHSN) Patient Safety Component for Healthcare Associated Infections (HAI)
• Understand the changes in NHSN due to the re-baselining
• Identify the impact of NHSN re-baselining on the Centers for Medicare & Medicaid Services (CMS) Value-Based Purchasing (VBP)
2
2017 NHSN Patient Safety Component Updates
3
Updates to Organisms Lists
Updates and additions to:
• NHSN All Organism list
• NHSN Mucosal Barrier list
• NHSN Common Commensal list
Complete lists available from the Centers for Disease Control and Prevention (CDC):
https://www.cdc.gov/nhsn/acute-care-hospital/clabsi/index.html
(Under Supporting Materials section)
4
Flow Diagram—Event Determination
5 Source: CDC, available at https://www.cdc.gov/nhsn/pdfs/pscmanual/pcsmanual_current.pdf
Building Blocks of NHSN Patient Component Surveillance Definitions
6 https://www.cdc.gov/nhsn/pdfs/pscmanual/pcsmanual_current.pdf
*See SSI surveillance protocol ˄See LabID and VAE surveillance protocols N/A = Not applicable
SSI = Surgical Site infection VAE = ventilator-associated pneumonia prevention
Transfer Rule
If the date of the event is the day of transfer/discharge, or the next day, the infection is
attributed to the transferring location.
7
Endocarditis (ENDO)
• Extended Infection Window Period (IWP) – 21 days
– 10 days before diagnostic test
– 10 days after the diagnostic test
• Extended Repeat Infection Timeframe (RIT) – Duration of admission
• Extended ENDO Secondary Bloodstream Infection (BSI) Attribution Period to the ENDO IWP and remaining duration of the admission for the organism that is used to meet the ENDO criterion
8
GIT (GI Tract) Criterion 2c Modification
• Patient has at least two of the following signs or symptoms compatible with infection of the organ or tissue involved: fever (>38˚ C), nausea, pain or tenderness, odynophagia or dysphagia
• And at least one of the following: – Organisms identified from blood by a culture or non-culture
based microbiologic testing method which is performed for purposes of clinical diagnosis or treatment. The organism(s) identified in the blood must contain at least one MBI organism: See Appendix A of the BSI protocol.
– AND – Imagining test evidence suggestive of gastrointestinal
infection, which if equivocal is supported by clinical correlation.
9 MBI = mucosal barrier injury
Other Definitional Changes for 2017
ORAL—Added back to criterion 3a, “from mucosal scrapings or exudate”
3. Patient has at least one of the following signs or symptoms with no other recognized cause: ulceration, raised white patches on inflamed mucosa, or plaques on oral mucosa
And at least one of the following:
a. Virus identified from mucosal scraping or excaudate by a culture or non-culture based microbiologic testing method which is performed for purposes of clinical diagnosis or treatment.
10
Other Definitional Changes for 2017
LUNG, SA, and NEC-provided guidance to allow clinical correlation to be used in cases where imaging tests are equivocal for infection.
• (LUNG 3) Patient has imaging test evidence of abscess or infection (excludes imaging test evidence of pneumonia) which if equivocal is supported by clinical correlation (i.e., physician documentation of antimicrobial treatment for lung infection).
11
SA = Spinal abscess without meningitis NEC = Necrotizing enterocolitis
Pathogen Assignment
• Additional eligible pathogens identified within a RIT are added to the event.
• Pathogen exclusions for specific infection definitions (ex. UTI, PNEU) also apply to secondary BSI pathogen assignment.
– Excluded pathogens must be attributed to another primary site-specific BSI.
• A BSI pathogen may be reported for more than one infection source.
12
UTI = urinary tract infection PNEU = pneumoccal
Central Line-Associated Bloodstream Infection (CLABSI) Changes
MBI Exclusion
• All facility types
• Exclude MBI-laboratory confirmed bloodstream infections (LCBIs)
Resources:
• MBI-LCBIs Guide: http://www.cdc.gov/nhsn/pdfs/ps-analysis-resources/mbianalysis.pdf
• Summary Data Line List: http://www.cdc.gov/nhsn/pdfs/ps-analysis-resources/summarylinelist.pdf
13 Source: CDC, available at https://www.cdc.gov/nhsn/pdfs/rebaseline/2015-rebaseline-sir-changes-applicable-to-cms-qrp.pdf
Surgical Site Infection (SSI) Changes
SSI Exclusions • Acute care hospitals • American Society of Anesthesiologists
(ASA) missing • BMI: If BMI>60 or BMI<12 • Gender is missing or gender is “O” • Medical affiliation is missing/incomplete (annual survey)
• Bed number missing (annual survey)
• Present at time of surgery (PATOS) • Age > 109 years • Procedure duration outliers • Closure technique missing
14
BMI = body mass index Source: CDC, available at https://www.cdc.gov/nhsn/pdfs/rebaseline/2015-rebaseline-sir-changes-applicable-to-cms-qrp.pdf
SSI Changes (cont.)
Resources
• Exclusion Criteria
http://www.cdc.gov/nhsn/pdfs/ps-analysis-resources/ssi-sir_tips.pdf
• Line List of Procedures http://www.cdc.gov/nhsn/pdfs/ps-analysis-resources/faq-procedure-line-list.pdf
• Analyzing Procedure Closure Technique
http://www.cdc.gov/nhsn/pdfs/ps-analysis-resources/proceduresclosuretechnique.pdf
15
Tools Available
• Electronic HAI Present on Admission (POA) Worksheet Generator – Requires user to ensure infection criterion are met and
to enter correct dates
– Generates worksheet with IWP, DOE, RIT, 2nd BSI Attribution Period
– Located under “Supporting Materials”
– Does not store information or send information to NHSN
16 Source: CDC, available at https://www.cdc.gov/nhsn/poa/index.html
American Journal of Infection Control NHSN Case-Study Series
• Additional educational tool
• Quarterly publication
• Addresses common surveillance scenarios
– CLABSI, CAUTI, VAE, SSI, MDRO/CDI
• Test your knowledge
• Quiz and answers via web link
17
CAUTI = catheter-associated urinary tract infections MDRO/CDI = multidrug-resistant organism & Clostridium difficile infection
Complete List Revisions
18 Source: CDC, available at https://www.cdc.gov/nhsn/pdfs/pscmanual/psc-january-2017-revisions.pdf
NHSN Changes and Re-baseline
19
NHSN v8.6—Re-baseline Highlights
• Baseline 2 = “New Standard Population” • Significant changes with definitions and decreased incidence
of HAIs • Used calendar year (CY) 2015 in-plan data as baseline • No more “pooled means” • New predictive/risk models
– Multivariable Logistic Regression Models (risk-adjustment)
– Negative Binomial Regression (probability)
– Logistic Regression (predictive)
• Standard Infection Ratios (SIRs) for Critical Access Hospitals (CAHs)
• More SIRs for long-term acute care hospitals (LTACH) and Inpatient Rehabilitation Facilities (IRFs)
20
Baseline Progression
21
HAI Type
Original National Baseline Data
2015 Re-baseline Acute Care
Hospitals (ACH)
Long-term Acute Care Hospitals
(LTACH)
Inpatient Rehabilitation Facilities (IRF)
CLABSIs 2006–2008 2013 2013 2015
CAUTIs 2009 2013 2013 2015
SSIs 2006–2008 None None 2015 (ACH only)
Hospital-onset C. difficile
2010–2011 None None 2015
Hospital-onset MRSA bacteremia
2010–2011 None None 2015
VAE
New—No Previous National Baseline Data
2015
MBI 2015
Standardized Utilization Ratio (SUR) (all device types)
2015
MRSA = Methicillin-resistant Staphylococcus aureus
Measures By Facility
22
HAI ACHs CAHs LTACHs IRFs
CLASBI (non-MBI)
Central Line SUR
MBI
CAUTI
Urinary Catheter SUR
VAE
Ventilator SUR
“All SSI” Models—Adults
“All SSI” Models—Peds
“Complex A/R” Models—Adults
“Complex A/R” Models—Peds
“Complex 30-day” Models—Adults (COLO and HYST)
MRSA Bacteremia LabID
CDI LabID
Separate from ACHs
COLO = Colon HYST = Hysterectomy A/R = Admission/Readmission
SSI SIR Model Review
• All SSI SIR Model – Inpatient only – Superficial, deep and organ/space SSI – Primary incision (superficial and deep) – On admission, readmission and post-discharge
• Complex A/R SSI Model (CDC HAI Progress Report) – Inpatient only – Only deep and organ/space SSI – On admission, readmission to facility
• Complex 30-Day SSI Model (CMS SSI Reporting) – In plan, Inpatient Colo and Hyster – Deep incisional primary and organ/space – Within 30 days of procedure
23
Impacting SIRs
• Annual Survey
• CDI Test Type
• Other Potential Risk Factors:
– Facility bed size
– Medical school affiliation
– Status as a cancer hospital
– Intensive care unit (ICU) location
– Pediatric location
24
Risk Variables
25
Factor CLABSI CLABSI (NICU) CAUTI VAE CDI MRSA
CDC Location
Facility Type
Medical School Affiliation
Inpatient Quarterly CO Prevalence Rate
CDI Test Type
Birthweight
Length of Stay
Reporting from ED/Obs Locations
Facility Bedsize
ICU Beds
Risk Variables (cont.)
26
Factor COLO HYST
Cancer Hospital
Patient Level Factors
Age
ASA Score
BMI
Closure technique
Diabetes
Gender
SIR Reference
27 Source: CDC, available at https://www.cdc.gov/nhsn/pdfs/ps-analysis-resources/nhsn-sir-guide.pdf
New Locations Added
28
Can now produce SIRs for the below units:
Mandatory CMS Reporting: • All Critical Care • All Medical Wards • All Surgical Wards • All Medical/Surgical Wards
CMS Value Based Purchasing FY 2018: • All Critical Care
IMPORTANT REMINDER!
CMS Value Based Purchasing FY 2019: • All Critical Care • Med, Surg, Med-Surg Wards
Standardized Utilization Ratio
• Summarized risk-adjusted measure
• Focuses on device use
• Uses multivariable logistic regression models
29
• Predicted number = 1
• >1 is higher utilization
• <1 is lower utilization
SUR = # observed device days
# predicted device days
Coming Soon
Year # CAUTI # pred SIR P-value 95% CI Cath Days
2015 7 2.523 2.774 0.0193 1.213, 5.488 5,996
Implications To Data
30
CAUTI – Example 1
Baseline 1:
New Baseline 2:
Year # CAUTI # pred SIR P-value 95% CI Cath Days
2015 7 10.401 0.673 0.2931 0.294,1.331 5,996
Implications To Data
31
CAUTI – Example 2
Baseline 1:
New Baseline 2:
Year # CAUTI # pred SIR P-value 95% CI Cath Days
2015 30 60.650 0.495 <0.0001 0.340, 0.697 16,963
Year # CAUTI # pred SIR P-value 95% CI Cath Days
2015 30 26.772 1.121 0.5218 0.770, 1.580 16,963
Baseline By Year
32
Do NOT use after CY 2016
Can use beginning CY* 2015
Only Use Baseline 2 CY 2017
and beyond
*Calendar Year
NHSN Changes and CMS
33
Re-baseline SIRs Shared with CMS
Hospital IQR LTCHQR IRFQR
CLABSI CLABSI CAUTI
CAUTI CAUTI
CDI
MRSA
SSI Hyster
SSI Colon
*Please note: this table does not include Healthcare Provider (HCP) Flu, as it is not impacted by the re-baseline.
34
The Old and New—What is CMS Seeing?
Baseline 1
Baseline 2
CMS will receive 6 quarters of data under Baseline 2.
35
Hospital Compare
36
Hospital Compare—Will use NHSN Baseline 2
“…data included in the December 2016 Quality Net Preview Reports will be calculated using the updated 2015 baseline and risk models.”
The Centers for Disease Control
https://www.cdc.gov/nhsn/pdfs/rebaseline/hospital-compare-verification-clabsi.pdf https://www.cdc.gov/nhsn/pdfs/rebaseline/hospital-compare-verification-ssi.pdf
Value-Based Purchasing
37
FY 2018 and FY 2019 VBP
Domain I: PSI 90 Composite–15% – PSI 3: Pressure Ulcers
– PSI 6: Iatrogenic Pneumothorax
– PSI 7: CLABSI*
– PSI 8: Post-Op Hip Fx
– PSI 12: VTE/PE
– PSI 13:Post-op Sepsis
– PSI 14: Wound Dehiscence
– PSI 15: Accidental Puncture
Domain II: HAI (NHSN)–85% – CLABSI* – CAUTI – SSI Hysterectomy – SSI Colon – MRSA Bacteremia – CDI
25%
25% 25%
Safety 25%
VBP Program Thresholds: Safety Domain
38
Measure VBP FY 2017 (Data CY 2015)
VBP FY 2018 (Data CY 2016)
VBP FY 2019 (Data CY 2017)
CAUTI 0.845 0.906 0.822*
CLABSI 0.457 0.369 0.860*
CDI 0.750 0.805 0.924
MRSA 0.799 0.767 0.854
SSI Hyster 0.698 0.710 0.762
SSI Colon 0.751 0.8244 0.783
PSI 90 0.777936 0.577321 0.774058
NHSN Re-baseline
*Note: FY2019 CAUTI and CLABSI = CC and MS Wards
VBP and NHSN Baselines
39
Payment Year NHSN Baseline Used
FY 2018 VBP CY 2016 Data
NHSN Baseline 1
FY 2019 VBP CY 2017 Data
NHSN Baseline 2
1
Reminder: CMS IPPS Reports
40
• “Snapshot” of what is being submitted on your behalf to CMS
• Validation of your submission • Only proof your data was entered
prior to the deadline • Means to verify data accuracy • Every submission, every time
CRITICAL
Important Reminders: CMS HAI Data
41
Every Journey Begins With a Good Map!
42
Avoids incorrect reporting to CMS
x http://www.cdc.gov/nhsn/PDFs/pscManual/15LocationsDescriptions_current.pdf
Accurate mapping is critical
How Mapping Can Impact Your SIRs
43
Unit Type IN:ACUTE:CC:ONC_M Critical Care Medical Oncology
IN:ACUTE:CC:M Critical Care Medical
Predicted CLABSI 4 1
Observed CLABSI 3 3
SIR 0.75 3.0
CAD* (Threshold: 0.369)
+1.24 +2.6
Correctly Map First: Improve Second!
*Cumulative Attributable Difference (CAD)
Mapping
• Re-evaluate at least annually – Location – Patient mix – Acuity
• Any changes in location – If just move a unit, you can remain. – If patient mix or acuity changes, you must map a new unit.
• Any changes in patient mix – Type of patient – Acuity of patients
• 80/20 rule – At least 80 percent of a particular patient type
• Virtual Units – When you don’t have 80 percent to map to a particular unit type, but enough
patients to skew your predicted number of infections – Example: a medical ward that routinely has a significant number of oncology
patients
44 Source: CDC, available at https://www.cdc.gov/nhsn/pdfs/pscmanual/15locationsdescriptions_current.pdf
NHSN Data Transition
45
Review: Baseline By Year
• Baseline 1 (old): Valid through CY 2016 data
• Baseline 2 (new): Valid beginning CY 2015 data
• CY 2017 and beyond, ONLY use Baseline 2 (new)
46
SIR Confusion
47
FY 2018 VBP CY 2016
Baseline 1
? ? ? ?
Trending Data
48
• You cannot continue trending from Baseline 1 into Baseline 2.
Incorrect
49
New Baseline Cannot continue trending beyond CY 2016
Correct Option
50
0
0.5
1
1.5
2
2.5
2012 2013 2014 2015 2016 2017 2018
SIR
Calendar Year
Community Memorial Hospital Trended CAUTI SIR
Baseline 1
Baseline 2
NHSN Re-baseline
Another Option
51
NOTE: FY2018/CY2016 data will be calculated using Baseline 1. Producing 2016 data using Baseline 2, while valid, may cause some confusion.
Accessing Baseline Set 1 Reports
52
“Old” Baseline Reports Baseline Set 1
Data Reporting
Facts: 1. For CY 2016 data, facilities will have more than one
“accurate” SIR. 2. VBP will use Baseline 1 and CY 2016 data. 3. Hospital Compare will use Baseline 2 and CY 2016 data. 4. You can go back to CY 2015 data using Baseline 2 for
trending purposes. 5. Select a baseline for internal reporting and stick to it for
CY 2016 data. 6. Only use Baseline 2 for CY 2017 data and beyond.
53
Questions?
54
Christine Martini-Bailey, RN, BSN, CSSGB Director, Quality Improvement and Patient Safety
cbailey@hsag.com | 614.307.2936
This material was prepared by Health Services Advisory Group, the Medicare Quality Improvement Organization for Arizona, California, Florida, Ohio, and the U.S. Virgin
Islands, under contract with the Centers for Medicare & Medicaid Services (CMS), an agency of the U.S. Department of Health and Human Services. The contents
presented do not necessarily reflect CMS policy. Publication No. QN-11SOW-D.1-04122017-01
55